[Rescheduling] GLP-1's and Eating Disorders: What clinicians are missing
The current weight loss medication landscape is rapidly reshaping weight-centric medical care - but their impact on eating disorder risk, presentation, and treatment is often overlooked. This continuing education talk explores the complex and under-recognized intersection between GLP-1 receptor agonist-containing medications (e.g., semaglutide, dulaglutide, and tirzepatide) and eating disorders across the diagnostic spectrum. Clinicians will examine how appetite suppression, weight loss reinforcement, and cultural weight bias may exacerbate disordered eating, mask symptoms, or delay diagnosis...Read more - particularly in patients with subclinical or atypical presentations. Of particular concern is the potential for GLP-1 receptor agonist-containing medications to induce or exacerbate malnutrition, complicating the clinical picture. The session will challenge common assumptions about “appropriate” candidates for GLP-1 receptor agonist-containing medications, highlight ethical and clinical blind spots, and offer practical guidance for screening, assessment, and interdisciplinary decision-making to support patient safety and recovery-oriented care. Less...
Learning Objectives
- Analyze the intersectional risks of GLP-1 medications across the eating disorder diagnostic spectrum, with a focus on how physiological appetite suppression and weight-loss reinforcement can exacerbate restrictive behaviors or trigger relapse in vulnerable populations.
- Assess the ethical and clinical considerations of prescribing GLP-1s to patients with a history of disordered eating, balancing medical indications (such as diabetes management) against the potential for destabilizing psychological recovery.
- Identify clinical "blind spots" and diagnostic delays caused by cultural weight bias, specifically examining how GLP-1 receptor agonist-containing therapy may mask symptoms in patients with atypical anorexia or subclinical presentations who do not fit traditional weight-centric stereotypes.
- Evaluate the nutritional implications of GLP-1 receptor agonist-containing medications specifically malnutrition, electrolyte imbalances, and micronutrient deficiencies.
Friday, May 01, 2026
12:00 PM EDT - 01:30 PM EDT
About the speakers
CE Information - Earn 1.5 CE Credit Hours
CE Approvals
Joint Accreditation
Commission on Dietetic Registration
Interprofessional Continuing Education
American Psychological Association
New York Education Department's State Board for Social Work
New York Education Department for Licensed Mental Health Counselors
New York State Education Department's State Board for Psychology
New York Education Department's State Board for Marriage and Family Therapy
CE Process Info
Before the event, you will receive an email from CE-Go with access to the virtual event. After the event, you will receive access to your evaluation and continuing education certificate via a personalized "attendee dashboard" link, hosted on the CE-Go website. This link and access to the virtual event will be sent to the email account you used to register for the event.
Upon accessing the CE-Go "attendee dashboard", you will be able to:
- Complete evaluation forms for the event
- Download your continuing education certificate in a PDF format
If you have any questions or concerns regarding the CE-Go platform, please contact CE-Go at 888-498-5578 or by email at support@ce-go.com Please Note: Emails for this event will come from "support@ceactivities.com".
If you have any continuing education related questions, please contact your event organizer.
Please make sure to check your spam/junk folder in case those emails get "stuck". We'd also suggest "Allowlisting" support@ceactivities.com. This tells your email client that you know this sender and trust them, which will keep emails from this contact at the top of your inbox and out of the junk folder.
Disclosure
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPSCE Learning Systems adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CE activity ― including faculty, planners, reviewers, or others ― are required to disclose all relevant financial relationships with ineligible entities (formerly known as commercial interests).
The following relevant financial relationships have been disclosed by this activity’s planners, faculty, and the reviewer:
PLANNERS AND REVIEWER
The planners of this activity have reported that they have no relevant financial relationships.
FACULTY
The faculty of this activity have reported that they have no relevant financial relationships.